Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this insightful session on understanding the Evolution in Treatment and Diagnosis of Lung Cancer. Manipal Hospitals, a leader in advanced medical care, is proud to present this initiative led by the esteemed Dr. Lalit Sharma. From conventional approaches to groundbreaking targeted therapies and immunotherapies, lung cancer treatment has undergone a significant transformation, offering renewed hope and improved outcomes for patients worldwide. This session aims to delve into these pivotal advancements, highlighting how a comprehensive understanding of evolving diagnostic tools and therapeutic strategies is paramount for delivering personalized and effective patient care.
The landscape of lung cancer management has been revolutionized by innovations in both diagnosis and treatment. Early detection, often facilitated by advanced imaging and novel biopsy techniques, now paves the way for more precise staging and tailored interventions. Furthermore, the advent of molecular profiling, including Next-Generation Sequencing (NGS), allows healthcare providers to identify specific genetic mutations within tumors, such as EGFR, ALK, ROS1, and BRAF. This precision medicine approach enables the selection of targeted therapies that directly address the underlying drivers of cancer, significantly enhancing efficacy and minimizing side effects compared to traditional chemotherapy.
Join us to gain comprehensive knowledge on the latest best practices in the evolution of lung cancer treatment and diagnosis. Dr. Lalit Sharma will share invaluable insights on navigating this rapidly advancing field, empowering medical professionals with the knowledge to optimize patient care and improve survival rates. Listen to this essential webinar, absorb the shared expertise, and continue to follow Hidoc for more such enriching educational sessions designed to keep you at the forefront of medical innovation.
See More Webinars @ Hidoc Webinars
1.
A Win for Molecularly Guided Therapy for Cancer of Unknown Primary
2.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
5.
Patients face high out-of-pocket costs after incident cancer diagnosis
1.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
2.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
3.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
4.
Interpreting Iron Studies: What Your Blood Results Really Mean
5.
Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation